New publications from collaborations

July 2021 - Letter: Spinal cord tractopathy in paraneoplastic anti-CV2/CRMP5...

An adenocarcinoma of the lung was diagnosed by biopsy in a 68-year-old man in August 2018. Two weeks later, the patient reported walking difficulties and bladder incontinence....

June 2021 - Letter: Secondary antibodies detection in LGI1...

Autoimmune encephalitis is usually suspected on the basis of clinical and paraclinical criteria and confirmed by the identification of specific antibodies in serum and/or CSF samples.This letter presents a case of an anti LGI-1 encephalitis where a diagnosis was made during follow-up.

May 2021- Article: Cerebrospinal Fluid IL-17A Could Predict...

This articles reports the concentrations of CSF sIL-2R, IL-6, IL-8, IL-10 and IL-17A and correlates it with acute disease severity and the 1-year outcome in non-NMDAR AE.

April 2021 - Article: Missense variants in DPYSL5 cause a neurodevelopmental

This study adds DPYSL5 to the list of genes implicated in brain malformation and in neurodevelopmental disorders.

 

Februrary 2021 - Article: Relationship between serum NMDA...

This article from our collaboration with T Pollak and al proposes a description of the role of ANMDA antibodies in psychosis onset and response to antipsychotic treatment.

October 2020 - Article: Psychiatric symptoms in anti glutamic...

The description of the neuropsychiatric spectrum of anti-GAD LE and its specificities aims to improve our understanding of this entity, and may lead to earlier diagnosis as well as better outcome.

September 2020 - Article: Clinical features, prognostic, and antibody...

BETPSY members participated to this scientific paper which aims is to clinically characterize patients with anti-metabotropic glutamate receptor (mGluR)1 encephalitis, identify prognostic factors, and study the IgG subclasses and effects of antibodies on neuronal mGluR1 clusters.